Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VXRT Vaxart Inc

-0.1299 (-12.49%)
Apr 12 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 2,475,633
Bid Price 0.905
Ask Price 0.93
News -
Day High 1.04


52 Week Range


Day Low 0.9001
Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.1299 -12.49% 0.9101 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.00 0.9001 1.04 0.9101 1.04
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,352 2,475,633 $ 0.9411896 $ 2,330,040 - 0.53 - 1.59
Last Trade Time Type Quantity Stock Price Currency
19:59:52 formt 2,000 $ 0.9101 USD

Vaxart Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
158.21M 173.86M - 7.38M -82.47M -0.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vaxart News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No VXRT Message Board. Create One! See More Posts on VXRT Message Board See More Message Board Posts

Historical VXRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.101.160.90011.051,541,698-0.1899-17.26%
1 Month1.111.410.90011.171,816,353-0.1999-18.01%
3 Months0.81151.540.7151.161,965,5910.098612.15%
6 Months0.69951.540.530.98807181,448,1940.210630.11%
1 Year0.6151.590.530.94990971,535,6890.295147.98%
3 Years5.5511.1080.535.784,035,944-4.64-83.60%
5 Years0.9524.900.25436.726,438,748-0.0399-4.20%

Vaxart Description

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Your Recent History

Delayed Upgrade Clock